Sentence examples for developed using either from inspiring English sources

Historically, models of crack deflection have been developed using either a strength-based or an energy-based fracture criterion.

Other types of polymer/silica hybrid fluorescence nanoparticles were also developed using either homo-PNIPAAm (PBM-b-N) or homo-PDMAAm (PBM-b-D) segments, instead of P NIPAAm-co-DMAAm).

The limited maps of biodiversity across the world's forested ecosystems were developed using either raster data or point data.

Other studies have been developed using either filter in frequency domain or windowing function in the time domain [10, 11].

Hence, these models are developed using either linear or non-linear mixed models in which site, stand, competition variables but also regional units or geographic coordinates are used as covariates (Lappi 1997; Eerikäinen 2003; Calama and Montero 2004; Mehtätalo 2004; Nanos et al. 2004; Hökkä, 1997; Schmidt et al. 2011).

Signals were developed using either colorimetric-fluorescent or fluorescent-fluorescent detection methods.

The reduced ENMs developed using localities from either K1 (average training and test AUC values of 0.994±0.001 SD and 0.992±0.002 SD, respectively) or K3 (average training and test AUC values of 0.981±0.004 SD and 0.982±0.018 SD, respectively) alone also performed well in predicting the range-wide distribution of A. transcaspicus (Figure 2).

When making such comparisons, it is important to recall that most international prognostic scores are developed using data either from trials or from selected groups of treated patients (International Non-Hodgkin's Lymphoma Prognostic Factors Project, 1993; Hasenclever and Diehl, 1998; Solal-Céligny et al, 2004).

For all the experiments, the membranes were either developed using ECL® (enhanced chemiluminescence) (Thermo Fisher) or scanned in the Odyssey system (LI-COR).

However, to date, only two molecular diagnostic tests, developed using DNA microarrays, have either been approved by the US Food and Drug Administration (MammaPrint) or incorporated into practise guidelines (Oncotype Dx) for clinical use in breast cancer (Weigelt et al, 2009).

Blots were developed using Amersham chemiluminescence kit (GE Health lifesciences, US).